Kaposi sarcoma
Generated by GPT-5-miniExpansion Funnel Raw 95 → Dedup 8 → NER 8 → Enqueued 5
| Kaposi sarcoma | |
|---|---|
 | |
| Name | Kaposi sarcoma |
| Field | Oncology, Infectious disease, Dermatology |
Kaposi sarcoma is a vascular tumor associated with immunosuppression and infection that most commonly affects skin, mucosa, and viscera. It was first described in the 19th century and later linked to a novel herpesvirus; modern recognition spans oncology, infectious disease, dermatology, and public health. Historical clinicians, virologists, and public health figures contributed to its characterization and management.
Signs and symptoms
Lesions typically present as violaceous macules, papules, plaques, or nodules on skin and mucous membranes, often on the lower extremities, face, oral cavity, and genitalia; notable clinicians and institutions such as Moritz Kaposi, Rudolf Virchow, Royal College of Physicians, Mayo Clinic and Johns Hopkins Hospital documented early clinical series. Cutaneous lesions may ulcerate or bleed, producing pain and lymphedema described in case reports from St Bartholomew's Hospital, Albert Einstein College of Medicine, and Massachusetts General Hospital; mucosal involvement commonly affects the oral cavity and oropharynx, with series reported by teams at Mount Sinai Hospital, UCLA Medical Center, and University College London Hospital. Visceral disease can involve the gastrointestinal tract, lungs, and lymph nodes, with presentations reported in cohorts from University of California San Francisco, Karolinska Institute, Institut Pasteur, and Centers for Disease Control and Prevention surveillance. Constitutional signs such as fever, weight loss, and night sweats were emphasized during the early AIDS epidemic by clinicians at San Francisco General Hospital, Hospital for Tropical Diseases (London), and research groups at National Institutes of Health and World Health Organization.
Cause and pathogenesis
The disease is caused by infection with human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma–associated herpesvirus, identified by investigators at Harvard University, Duke University, Fred Hutchinson Cancer Center, University of Edinburgh, and National Cancer Institute. Viral oncogenes and cytokine dysregulation drive proliferation of spindle cells derived from endothelial lineage; molecular pathways were elucidated in laboratories at Cold Spring Harbor Laboratory, Max Planck Institute, Salk Institute, and Weizmann Institute of Science. Host immunosuppression—whether iatrogenic after organ transplantation managed by teams at Cleveland Clinic, Stanford Health Care, Karolinska University Hospital or from advanced immunodeficiency in cohorts observed at San Francisco General Hospital, National Institute for Communicable Diseases (South Africa), and Kenyatta National Hospital—permits HHV-8 reactivation and tumor growth. Coinfections and genetic susceptibility factors have been explored in epidemiological studies conducted by Johns Hopkins Bloomberg School of Public Health, University of Cape Town, London School of Hygiene & Tropical Medicine, and Columbia University, implicating inflammatory mediators and angiogenic factors characterized in work from University of Cambridge, Yale University, and University of Toronto.
Diagnosis
Diagnosis relies on clinical examination supplemented by histopathology, immunohistochemistry, and molecular testing used in laboratories at Mayo Clinic Laboratories, Quest Diagnostics, Sheba Medical Center, and university pathology departments at University of Oxford, University of Melbourne, and Seoul National University Hospital. Skin biopsy classically shows proliferating spindle-shaped cells, slit-like vascular spaces, and extravasated erythrocytes; pathologists at Memorial Sloan Kettering Cancer Center, The Royal Marsden Hospital, and University of Pennsylvania Health System have published diagnostic criteria. Immunohistochemical staining for latent nuclear antigen-1 (LANA-1) of HHV-8 and PCR-based detection of viral DNA are standard in clinical virology units such as those at Centers for Disease Control and Prevention, Public Health England, and Institut Pasteur. Radiologic assessment using endoscopy, computed tomography, and chest imaging—routinely performed at Mayo Clinic, UCLA Health, and Guy's and St Thomas' NHS Foundation Trust—evaluates visceral involvement; multidisciplinary tumor boards at Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and Royal Free Hospital guide staging and management.
Classification and types
Historically described clinical variants include classic (Mediterranean), endemic (African), epidemic (AIDS-related), and iatrogenic (transplant-associated) forms; epidemiological descriptions were shaped by investigators at University of Padua, University of Athens, University of Nairobi, University of the Witwatersrand, and University of São Paulo. Classic Kaposi sarcoma was characterized in case series from Vienna General Hospital and University of Rome La Sapienza; endemic forms were defined by cohorts in regions served by Makerere University Hospital and University of Lagos Teaching Hospital; epidemic forms were recognized during the HIV/AIDS crisis with seminal contributions from San Francisco General Hospital, Royal Free Hospital, and University of Miami. Iatrogenic disease following solid-organ transplantation was reported by teams at Edmonton General Hospital, Hospital Clínic de Barcelona, and St Thomas' Hospital. Subclassification also considers cutaneous-limited versus visceral disease as used in clinical trials at National Cancer Institute, European Organisation for Research and Treatment of Cancer, and US Food and Drug Administration-sponsored studies.
Treatment
Management includes local therapies, systemic antineoplastic agents, and modulation of immune suppression—approaches developed across oncology centers including MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Royal Marsden Hospital, Peter MacCallum Cancer Centre, and Vall d'Hebron University Hospital. Local treatments such as surgical excision, radiation therapy, cryotherapy, and intralesional chemotherapy were refined by teams at Mayo Clinic, Cleveland Clinic, Institut Gustave Roussy, and St Jude Children's Research Hospital. Systemic chemotherapy agents commonly used in trials and practice include liposomal anthracyclines and taxanes, evaluated in multicenter studies coordinated by European Society for Medical Oncology, American Society of Clinical Oncology, National Cancer Institute, and Children's Oncology Group. Antiretroviral therapy dramatically reduced epidemic disease incidence after implementation by public health programs in United States Public Health Service, UNAIDS, and national HIV programs in South Africa and Brazil; transplantation-associated cases may respond to reduction of immunosuppression as practiced at Cleveland Clinic and Addenbrooke's Hospital. Targeted and immunomodulatory therapies—bevacizumab, interferon-alpha, and checkpoint inhibitors—are under investigation in trials at Fred Hutchinson Cancer Center, Vanderbilt University Medical Center, University of California San Diego Health, and National Institutes of Health Clinical Center.
Epidemiology and risk factors
Incidence varies geographically and by population: higher prevalence in Mediterranean Basin countries studied by University of Athens and Sapienza University of Rome, sub-Saharan Africa cohorts described by University of Cape Town and University of Nairobi, and among people living with HIV/AIDS documented by surveillance at Centers for Disease Control and Prevention, Public Health England, and Programa Nacional de DST e AIDS (Brazil). Risk factors include HHV-8 seropositivity identified in seroepidemiologic surveys by Johns Hopkins University, London School of Hygiene & Tropical Medicine, and Karolinska Institute; immunosuppression after organ transplantation quantified in registries at Organ Procurement and Transplantation Network and European Renal Association; and HIV infection, with burden reduced where antiretroviral programs from PEPFAR, UNAIDS, and national ministries of health have been implemented. Demographic associations—male predominance, older age for classic form, and younger age for endemic form—were reported in population studies from Italian National Institute of Health, South African Medical Research Council, and Brazilian Ministry of Health.